5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Nath Bio-Genes (India) Ltd.

•
nathbiogenes.comBSE: 537291NSE: NATHBIOGEN
Market Cap₹ 281 Cr.
Current Price
High / Low₹ 204 / 126
Stock P/E7.7
Book Value₹ 375
Price to Book0.43
Dividend Yield1.35 %
ROCE6.9 %
ROE6.2 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Agriculture Activities: 87.5% • Trading Activities: 12.5%

AI Sector View

AI GENERATED

Fast Moving Consumer Goods

Hold

Rural demand proxies are mixed. Tractor sales rose 18.0% YoY (2026-07) and 2-wheelers were up 23.0% YoY (2026-06), but rural employment slowed to 1.0% YoY (2026-07), fertiliser sales were 0.0% YoY (2026-05), and food inflation of 5.52% (Jul/26) can pressure household budgets. FPI outflows remain heavy at INR -8081 crore over 3 months to 2026-08-31, limiting upside.

Confidence
62%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 33.2% CAGR over last 5 years
  • Company has delivered good sales growth of 24.1% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.15x)
  • Company generates healthy free cash flow
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 55.3% versus prior year
  • Company has a low return on capital employed of 7.1%
  • Company has a low return on equity of 6.4% over last 3 years
  • Effective tax rate is unusually low at 4.9% - earnings may be flattered
  • Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Fast Moving Consumer GoodsAgriAgriculture
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.KSCL715.7514.753681.750.00279.84-14.47742.50-13.5121.7739.58
2.VENKEYS1786.55366.342516.770.5649.99215.791118.3829.1711.276.18
3.AVTNPL89.9616.351369.950.8931.10156.69241.2282.1614.2616.56
4.BSHSL90.0032.92944.440.0014.3016.56182.5719.3721.199.39
5.REGAAL83.8314.43863.400.3013.3346.95202.15-18.0216.9115.33
6.MGEL15.9411.13525.310.0684.261210.019520.651008.9319.371.94
7.NATHBIOGEN147.807.67280.881.3532.26-13.46328.4015.766.8910.70
8.MSL149.0019.67163.600.003.971.9361.8425.8112.349.28
9.INDOUS77.6130.74155.620.003.04-35.3832.997.2121.1512.01
10.OSWALSEEDS15.5411.64142.140.0012.2768.60117.0819.539.8815.65
11.NARMADA14.3130.22108.570.007.54—222.63—8.944.25
12.AGRITECH99.950.0059.370.00-3.6161.180.00—-0.94—
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
235233243244323752284446652328
198182639207272952245386247299
Operating Profit37564375803864430
OPM %15.65%22.06%17.80%9.13%14.98%14.94%21.78%0.79%13.49%13.91%5.41%8.66%9.10%
0030000422441
Interest3231234134554
Depreciation1111111111111
Profit before Tax33252341423632233
Tax %0.66%18.92%16.78%27.07%0.74%-2.75%30.08%40.13%1.84%18.88%35.08%100.40%2.19%
Net Profit00003313153732-032
17.470.792.021.8717.490.531.390.4219.581.400.84-0.7916.98

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025TTM
124138278301333365490
109118241252283315446
Operating Profit15203749505044
OPM %11.84%14.45%13.37%16.25%15.02%13.69%8.99%
11-8714511
Interest24111091117
Depreciation5533344
Profit before Tax912-6336424141
Tax %-1.38%4.48%-6.23%3.19%4.68%4.89%11.44%
Net Profit912-6735403937
EPS0.000.00-35.5518.4320.8520.31—
Dividend Payout %0.00%0.00%-5.64%10.85%9.59%9.85%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
24%
3 Years:
9%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
33%
3 Years:
—

STOCK PRICE CAGR

10 Years:
4%
5 Years:
-15%
3 Years:
-11%
1 Year:
-13%

RETURN ON EQUITY

10 Years:
—
5 Years:
4%
3 Years:
6%
Last Year:
6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 11

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2025

Aug 14

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2024

Aug 9

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2023

Jul 4

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2022

Jun 23

₹ 0.20

Rs.2.0000 per share(20%)Dividend

2021

Aug 18

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2026

Sep 7

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital161619191919
3041523554591625
91892104109121
Trade Payables162843284379
48546387118181
Total Liabilities1191577397938801,026
2138245244249250
105566
6677220208230338
00009489
Cash & Bank324387789
2940265298223254
Total Assets1191577397938801,026

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025
01520397518
Cash from Investing0-21-20-3-27-4
Cash from Financing06-22-2-8-2
0-1-25343911

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
45.6045.6045.6045.6045.6045.6045.6045.6045.60
0.210.180.190.210.410.320.310.220.26
4.374.374.373.942.250.760.010.010.01
Government0.000.000.000.000.000.000.000.000.00
49.8249.8549.8450.2551.7453.3254.0854.1754.13

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-09
Clarification - Financial Results

2026-09-09 - The Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

2026-09-01
Record Date

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-06
Initiation of Forensic Audit

2026-08-06 - Nath Bio-Genes (India) Limited has informed the Exchange about Initiation of Forensic Audit

2026-07-30
General Updates

2026-07-30 - Nath Bio-Genes (India) Limited has informed the Exchange about General Updates

2026-07-29
Outcome of Board Meeting

2026-07-29 - Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-23
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-23 - Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-06-26
Trading Window

2026-06-26 - Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-19
Disclosure under SEBI Takeover Regulations

2026-06-19 - Nath Bio-Genes (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

News

Recent coverage and analyst commentary for NATHBIOGEN

Loading news…

🤖

AI Stock Analyst

Nath Bio-Genes (India) Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login